Back
Regeneron Pharmaceuticals Stock Price Chart
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
982.60
Seasonality Move:
8.1%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 973.46 | Buy |
| 20-day SMA: | 939.22 | Buy |
| 50-day SMA: | 942.8 | Buy |
| 200-day SMA: | 880.68 | Buy |
| 8-day EMA: | 970.66 | Buy |
| 20-day EMA: | 952.53 | Buy |
| 50-day EMA: | 942.21 | Buy |
| 200-day EMA: | 886.86 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.5 | Buy |
| Relative Strength Index (14 RSI): | 64.04 | Buy |
| Chaikin Money Flow: | 364335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (893.96 - 967.54) | Buy |
| Bollinger Bands (100): | (910.83 - 972.27) | Buy |
Regeneron Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 982.29 while REGN 8-day simple moving average is 973.46, which is a Buy signal.
- The stock price of REGN is 982.29 while Regeneron Pharmaceuticals 20-day SMA is 939.22, which makes it a Buy.
- Regeneron Pharmaceuticals 50-day simple moving average is 942.80 while REGN share price is 982.29, making it a Buy technically.
- REGN stock price is 982.29 and Regeneron Pharmaceuticals 200-day simple moving average is 880.68, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $982.29. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
108.23B
Price in USD:
982.29
Share Volume:
386.46K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
998.33
52-Week Low:
684.81
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 982.29 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 982.29 while REGN 8-day exponential moving average is 970.66, which is a Buy signal.
- The stock price of REGN is 982.29 while Regeneron Pharmaceuticals 20-day EMA is 952.53, which makes it a Buy.
- Regeneron Pharmaceuticals 50-day exponential moving average is 942.21 while REGN share price is 982.29, making it a Buy technically.
- REGN stock price is 982.29 and Regeneron Pharmaceuticals 200-day simple moving average is 886.86, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is 14.5, suggesting Regeneron Pharmaceuticals is a Buy
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 64.04, which suggest Regeneron Pharmaceuticals is overbought
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (893.96 - 967.54), which suggest Regeneron Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (910.83 - 972.27), which suggest Regeneron Pharmaceuticals is a Buy
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.